Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of authorisation: 22/11/2021, Revision: 7, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 28 July 2026 - 14:50

Human medicines European public assessment report (EPAR): Trodelvy, sacituzumab govitecan, Date of authorisation: 22/11/2021, Revision: 7, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/trodelvy

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters